HX
Income statement / Annual
Last year (2024), Akso Health Group's total revenue was $2.41 M,
a decrease of 81.68% from the previous year.
In 2024, Akso Health Group's net income was -$9.46 M.
See Akso Health Group,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$2.41 M |
$13.18 M |
$6.31 M |
$1.75 M |
$11.44 M |
$61.33 M |
$107.26 M |
$22.92 M |
$11.89 M |
$4.65 M |
| Cost of Revenue |
$2.29 M
|
$11.91 M
|
$5.39 M
|
$544,572.00
|
$4.99 M
|
$7.40 M
|
$8.50 M
|
$5.15 M
|
$2.36 M
|
$1.61 M
|
| Gross Profit |
$122,132.00
|
$1.27 M
|
$916,226.00
|
$1.21 M
|
$6.44 M
|
$53.93 M
|
$98.76 M
|
$17.77 M
|
$9.54 M
|
$3.04 M
|
| Gross Profit Ratio |
0.05
|
0.1
|
0.15
|
0.69
|
0.56
|
0.88
|
0.92
|
0.78
|
0.8
|
0.65
|
| Research and Development Expenses |
$0.00
|
-$0.99
|
$421,186.00
|
$544,572.00
|
$1.03 M
|
$0.00
|
$2.82 M
|
$5.15 M
|
$2.36 M
|
$1.61 M
|
| General & Administrative Expenses |
$8.59 M
|
$15.53 M
|
$15.39 M
|
$27.27 M
|
$26.80 M
|
$16.51 M
|
$7.64 M
|
$2.65 M
|
$1.55 M
|
$733,920.00
|
| Selling & Marketing Expenses |
$168,421.00
|
$6,661.00
|
$240,927.00
|
$1.09 M
|
$16.47 M
|
$32.32 M
|
$15.24 M
|
$5.21 M
|
$3.84 M
|
$2.61 M
|
| Selling, General & Administrative Expenses |
$8.76 M
|
$15.54 M
|
$15.63 M
|
$28.36 M
|
$43.27 M
|
$48.84 M
|
$22.89 M
|
$7.86 M
|
$5.39 M
|
$3.34 M
|
| Other Expenses |
$0.00
|
$1.20 M
|
-$780,546.00
|
-$164,918.00
|
$1.60 M
|
$2.31 M
|
$660,877.00
|
$179,529.00
|
$26,270.00
|
-$7,704.00
|
| Operating Expenses |
$8.76 M
|
$15.54 M
|
$16.05 M
|
$28.36 M
|
$43.27 M
|
$48.84 M
|
$22.89 M
|
$7.86 M
|
$5.39 M
|
$3.34 M
|
| Cost And Expenses |
$11.05 M
|
$27.45 M
|
$21.44 M
|
$28.90 M
|
$48.26 M
|
$56.23 M
|
$31.38 M
|
$13.01 M
|
$7.75 M
|
$4.94 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$590,122.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$804,138.00
|
$2.15 M
|
$2.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$138,240.00
|
$18,390.00
|
$18,390.00
|
$15,161.00
|
$120,520.00
|
$406,799.00
|
$174,384.00
|
$92,224.00
|
$61,392.00
|
$19,701.00
|
| EBITDA |
-$8.50 M |
-$14.25 M |
-$3.26 M |
-$2.07 M |
-$18.80 M |
-$6.79 M |
$76.05 M |
$10.01 M |
$4.20 M |
-$278,924.00 |
| EBITDA Ratio |
-3.52
|
-0.99
|
-2.52
|
-15.56
|
-3.03
|
0.08
|
0.71
|
0.44
|
0.35
|
-0.06
|
| Operating Income Ratio |
-3.58
|
-1.08
|
-2.4
|
-15.47
|
-3.22
|
0.08
|
0.71
|
0.43
|
0.35
|
-0.06
|
| Total Other Income/Expenses Net |
-$453,751.00
|
$1.20 M
|
-$747,818.00
|
-$3.92 M
|
$1.23 M
|
$381,150.00
|
$660,877.00
|
$179,529.00
|
$26,270.00
|
-$7,704.00
|
| Income Before Tax |
-$9.09 M
|
-$13.07 M
|
-$16.72 M
|
-$31.07 M
|
-$66.93 M
|
$7.41 M
|
$76.54 M
|
$10.09 M
|
$4.17 M
|
-$306,329.00
|
| Income Before Tax Ratio |
-3.77
|
-0.99
|
-2.65
|
-17.7
|
-5.85
|
0.12
|
0.71
|
0.44
|
0.35
|
-0.07
|
| Income Tax Expense |
$24,988.00
|
$17,549.00
|
$131,433.00
|
$482,976.00
|
$4.27 M
|
$1.87 M
|
$11.03 M
|
$1.52 M
|
$628,246.00
|
$43,842.00
|
| Net Income |
-$9.46 M
|
-$13.08 M
|
-$16.85 M
|
-$31.55 M
|
-$71.20 M
|
$5.53 M
|
$65.48 M
|
$8.57 M
|
$3.54 M
|
-$350,171.00
|
| Net Income Ratio |
-3.92
|
-0.99
|
-2.67
|
-17.98
|
-6.23
|
0.09
|
0.61
|
0.37
|
0.3
|
-0.08
|
| EPS |
-0.21 |
-0.57 |
-0.85 |
-1.94 |
-4.38 |
0.31 |
4.12 |
0.54 |
0.22 |
-0.0219 |
| EPS Diluted |
-0.2 |
-0.57 |
-0.85 |
-1.94 |
-4.38 |
0.31 |
4.12 |
0.54 |
0.22 |
-0.0219 |
| Weighted Average Shares Out |
$45.04 M
|
$22.87 M
|
$19.87 M
|
$16.28 M
|
$16.25 M
|
$17.64 M
|
$15.89 M
|
$15.97 M
|
$15.97 M
|
$15.97 M
|
| Weighted Average Shares Out Diluted |
$47.17 M
|
$22.87 M
|
$19.87 M
|
$16.28 M
|
$16.25 M
|
$17.64 M
|
$15.89 M
|
$15.97 M
|
$15.97 M
|
$15.97 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
